La Bio Med » LA BioMed Investigators

Search Directory « ‹ of 6 › »

A B C D

	Sharon G. Adler, M.D. Principal Investigator Nephrology and Hypertension Work Division of Nephrology and Hypertension Harbor-UCLA Medical Center 1000 West Carson St. , C-1 Annex Torrance CA 90509 United Stateswork Work Phone: 310.222.3891work Work Email: sadler@labiomed.orgINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Professor of Medicine, David Geffen School of Medicine, Harbor-UCLA Medical Center Associate Director, Division of Nephrology and Hypertension Associate Director, Nephrology Fellowship Training Program Program Director, Nephrology Fellowship Training Program Chief, Division of Nephrology and Hypertension Principal Investigator, LA BioMed Dr. Sharon Adler is internationally known for her experimental and clinical research in all aspects of diabetic kidney disease and glomerulonephritis. Her current work focuses on discerning why patients with even mild kidney disease suffer death and disability from heart disease. She recently discovered molecules in the urine that facilitate the identification of kidney disease early on; this discovery is expected to open up new avenues for the treatment of kidney disease. Included on the Best Doctors of America list each year since 1996, as well as on similar lists published throughout southern California, Dr. Adler has amassed an impressive number of awards and honors from the scientific and medical communities. Of note was the receipt, in 2001, of the Juvenile Diabetes Research Foundation’s Mary Jane Kugel award; the 2004 Spirit of Nephrology award from the National Kidney Foundation of Southern California and, in 2011, the National Kidney Foundation’s coveted Donald Seldin Award. A member of the American Board of Internal Medicine Nephrology Board from 2002-2008, Dr. Adler has submitted more than 80 peer-reviewed papers to professional journals and conferences. Her research has been funded by the National Institutes of Health, the American Diabetes Association and the Juvenile Diabetes Research Foundation. Dr. Adler began her collegiate education and training in New York, earning a bachelor of arts degree from Barnard College and her medical degree from the State University of New York (SUNY) Downstate. After an internship at the Long Island Jewish Medical Center, Dr. Adler arrived in California, where she completed a residency at Loma Linda University Medical Center and served there as medicine chief resident from 1979 through 1980. She began her tenure at Harbor-UCLA Medical Center as a nephrology fellow, performing both research and clinical care during her fellowship. EDUCATION M.D., 1976, State University of New York (SUNY) Downstate, Medical Center College Of Medicine Post-Doctoral Fellow, 1983, Los Angeles County Harbor-UCLA Medical Center Residency, 1980, Loma Linda University Medical Center Internship, 1977, Long Island Jewish Hospital ACADEMIC APPOINTMENTS Professor of Medicine, David Geffen School of Medicine, Harbor-UCLA Medical Center Associate Director, Division of Nephrology and Hypertension Program Director, Nephrology Fellowship Training Program Chief, Division of Nephrology and Hypertension Principal Investigator, LA BioMed AWARDS & RECOGNITIONS Regents Scholarship, 1968-72 Barnard College Dean’s List, 1970-72 Harbor-UCLA Collegium Research Award, 1984 Los Angeles Magazine Best Doctors in L.A., Southern California Super Doctors 2008 – 2010 Best Doctors in America – Pacific Region, 1996 – 2011 Top Women Southern California Super Doctors, 2011 PUBLICATIONS Recent and/or Significant Studies: Change in ankle-brachial index over time and mortality in diabetics with proteinuria. Jiwakanon S, Adler S, Mehrotra R. Clin Nephrol. 2012 Jul 12. Oxidized low-density lipoprotein antigen transport induces autoimmunity in the renal tubulointerstitium. Satirapoj B, Bruhn KW, Nast CC, Wang Y, Dai T, Lapage J, Wu X, Natarajan R, Adler SG. Am J Nephrol. 2012;35(6):520-30. Epub 2012 May 25. Novel insights into the relationship between glomerular pathology and progressive kidney disease. Satirapoj B, Nast CC, Adler SG. Adv Chronic Kidney Dis. 2012 Mar;19(2):93-100. Review. See More Publications

	Thomas L. Anderson, M.D. Principal Investigator Physician Specialist Work LA BioMed 1124 W. Carson Street, Bldg N-25 Department of Neurology Torrance CA 90502 work Work Phone: 310.222.3987work Work Email: tanderson@labiomed.orgINTERNET
Show Bio	Show Map \|
Biography OVERVIEW We are sorry for the inconvenience. This page is currently being updated. Please try again later. Thank you.

A B C D

	Susan Ballagh, M.D. Principal Investigator Associate Professor of Clinical Obstetrics and Gynecology Work Harbor-UCLA Medical Center Department of Obstetrics and Gynecology 1000 West Carson Street, Box 3A Torrance CA 90509 work Work Phone: 310.222.1289work Work Email: sballagh@obgyn.humc.eduINTERNET
Show Bio	Show Map \|
Biography OVERVIEW We are sorry for the inconvenience. This page is currently being updated. Please try again later. Thank you.

	Fawzia Bardag-Gorce, Ph.D. Principal Investigator Division of Hematology Work Division of Hematology Harbor-UCLA Medical Center 1124 W. Carson Street, C1 Room 12 Torrance CA 90502 work Work Phone: 310.222.2483work Work Email: fgorce@labiomed.orgINTERNET Work Email: fgorce@ucla.eduINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Dr. Fawzia Bardag-Gorce investigated the ubiquitin-proteasome pathway in alcoholic liver disease and reported the beneficial effects of proteasome inhibitor treatment in preventing oxidative stress, inflammation, as well as reducing fatty acid, triglycerides and cholesterol synthesis. She is currently working in the field of regenerative medicine and had succeeded in engineering autologous cell sheets for corneal epithelium regeneration in a rabbit model of stem cell deficiency. EDUCATION Master in Cellular & Molecular Physiology; 1994; Blaise Pascal University, France PhD in Biochemistry; 1999; Blaise Pascal University, France Post-Doctoral Research Associate, 2000, Dept. of Pathology, Harbor-UCLA Medical Center. ACADEMIC APPOINTMENTS Associate Researcher, Step I, Dept. of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Torrance, CA. Investigator, LA BioMed AWARDS & RECOGNITIONS 2006 Travel Award – International Society for Biomedical Research on Alcoholism, ISBRA 2006 World Congress on Alcoholism Research September 10-13 Sydney, Australia. 2006 Travel Award – Research Society on Alcoholism, RSoA 29th Annual scientific meeting June 24-23 2006, Baltimore, MD. 2003 Best Poster Award – The Research Center for Alcoholic Liver and Pancreatic Diseases Cirrhosis Research Program, 5th Annual Symposium – University of Southern California, Los Angeles, CA. 2001 Best Annual Communication Award – The Research Center for Alcoholic Liver and Pancreatic Diseases Cirrhosis Research Program, 3rd Annual Symposium – University of Southern California, Los Angeles, CA. 2000 Travel Award – Japanese Hepatology Society and International Society of Biomedical Research on Alcoholism. 10th Congress, Yokohama, Japan. PUBLICATIONS Recent and/or Significant Studies: The effect of ethanol-induced CYP2E1 on proteasome activity: the role of 4-hydroxynonenal. Bardag-Gorce F, Li J, French BA, French SW. Exp Mol Pathol. 2005 Apr;78(2):109-15. Epub 2004 Dec 31. Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Oliva J, French SW, Li J, Bardag-Gorce F. Exp Mol Pathol. 2012 Aug;93(1):26-34. PMID: 22445925 Chronic ethanol feeding affects proteasome-interacting proteins. Bousquet-Dubouch MP, Nguen S, Bouyssié D, Burlet-Schiltz O, French SW, Monsarrat B, Bardag-Gorce F. Proteomics. 2009 Jul;9(13):3609-22. PMID: 19609968.

	Arnold S. Bayer, M.D,FACP, FCCP, FIDSA Principal Investigator Division of Infectious Diseases Work Dept. of Medicine Infectious Diseases Harbor-UCLA Medical Center 1124 West Carson St,.RB2 Torrance CA 90502 work Work Phone: 310.222.6422work Work Email: abayer@labiomed.orgINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Associate Program Director, Infectious Disease, Harbor-UCLA Medical Center Associate Chief, Adult Infectious Diseases, David Geffen School of Medicine, Harbor-UCLA Medical Center Professor of Medicine (in Residence), David Geffen School of Medicine, Harbor-UCLA Medical Center; Faculty, Internal Medicine, Harbor-UCLA Medical Center Vice Chair for Academic Affairs, Department of Medicine, Harbor-UCLA Medical Center Senior Investigator, LA BioMed Dr. Bayer’s main area of research focuses on expression of key virulence factors and genes which enhance the ability of S. aureus to cause endovascular infections. In a faculty career spanning more than 30 years, Dr. Arnold Bayer has dedicated himself to deepening our understanding of infectious disease. He continues to study the ways in which the human body responds to infection and builds up resistance to antibiotics, with an ultimate goal of developing strategies for effectively fighting off pathogens. With funding from both NIH/NIAID and private sector pharmaceutical sources, Dr. Bayer is conducting research related to the mechanisms by which platelet peptides kill common blood stream pathogens, as well as to the study of the genetic mechanisms by which certain strains of bacteria develop resistance and cross-resistance to antibiotics. In addition to his numerous responsibilities within the Harbor-UCLA Medical Center community, Dr. Bayer plays an active role in the international medical and academic spheres. A co-author of well over 200 scientific papers, book chapters and major reviews and a frequent lecturer and presenter on topics concerning infectious disease, Dr. Bayer has served on national committees, including the National American Heart Association’s Committee on Rheumatic Fever, Endocarditis & Kawasaki’s Disease; NIAID’s National Association for Research in Staphylococcus aureus (NARSA); and, the International Society on Cardiovascular Infectious Diseases (ISCVID). He is a charter committee member of the International Consortium for the Study of Infective Endocarditis (ICE) and he also serves as ongoing principal investigator and steering committee member for the Consortium’s UCLA site. Dr. Bayer began his medical education on the East coast, earning his degree from Temple University School of Medicine in Philadelphia, Pennsylvania. After completing an internship and junior residency program at Thomas Jefferson University Hospital, also in Philadelphia, Dr. Bayer came to Harbor-UCLA Medical Center as a senior resident in Internal Medicine, and a Clinical-Research Fellow in infectious diseases. Immediately thereafter, he began post-doctoral research fellowship in infectious diseases at Wadsworth VA Medical Center in Los Angeles, CA, before joining the faculty at Harbor-UCLA and LA Biomed. EDUCATION M.D., 1970, Temple University School of Medicine Fellowship, 1974-1977, Harbor-UCLA Medical Center, Division of Infectious Diseases Residency, 1971-1973, Thomas Jefferson University Hospital, Philadelphia, PA Internship, 1970-1971, Thomas Jefferson University Hospital, Philadelphia, PA ACADEMIC APPOINTMENTS Associate Program Director, Infectious Disease, Harbor-UCLA Medical Center Associate Chief, Adult Infectious Diseases, David Geffen School of Medicine, Harbor-UCLA Medical Center Professor of Medicine (in Residence), David Geffen School of Medicine, Harbor-UCLA Medical Center; Faculty, Internal Medicine, Harbor-UCLA Medical Center Vice Chair for Academic Affairs, Department of Medicine, Harbor-UCLA Medical Center Senior Investigator, LA BioMed AWARDS & RECOGNITIONS Chair-Elect – Gordon Research Conference On Staphylococcal Diseases, Salve Regina College, 2005 Invited Speaker – ”New Virulence Gene Targets in Staphylococci.” Western Association of Physicians Meeting, Carmel, CA. State-of-the-Art Lecture, 2005 Discussion Leader and Lecturer – ”Novel Antivirulence Approaches to Staphylococcal Infections” – Gordon Research Conference on Staphylococcal Diseases, Roger Williams College, RI 2001 Vice-Chair Elect – Gordon Research Conference On Staphylococcal Diseases, Oxford, UK 2003 PUBLICATIONS Recent and/or Significant Studies: Divergent Responses of Different Endothelial Cell Types to Infection with Candida albicans and Staphylococcus aureus. Seidl K, Solis NV, Bayer AS, Hady WA, Ellison S, Klashman MC, Xiong YQ, Filler SG. PLoS One. 2012;7(6):e39633. Epub 2012 Jun 22. Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat. Hady WA, Bayer AS, Xiong YQ. J Vis Exp. 2012 Jun 4;(64). pii: 3863. doi: 10.3791/3863. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, Miró JM, Ninot S, Fernández-Hidalgo N, Durante-Mangoni E, Spelman D, Hoen B, Lejko-Zupanc T, Cecchi E, Thuny F, Hannan MM, Pappas P, Henry M, Fowler VG Jr, Crowley AL, Wang A; ICE-PCS Investigators. JAMA. 2012 Apr 25;307(16):1727-35.

	Michele S. Berk, Ph.D. Principal Investigator Child and Adolescent Psychiatry Work Harbor-UCLA Medical Center 1000 West Carson Street, Box 498 Torrance CA 90509 work Work Phone: 310.222.1607work Work Email: mberk@labiomed.orgINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Dr. Michele Berk has committed herself to the study, advancement, and teaching of cognitive-behavioral treatments for suicidal behavior in self-injurious adolescents with emotional dysregulation. Her research addresses the critical need for effective treatments for adolescents at risk for suicide. In particular, Dr. Berk’s work focuses on determining if Dialectical Behavior Therapy (DBT) is effective with suicidal teens. EDUCATION M.D., Ph.D., New York University (NYU), Clinical Psychology Fellowship, 2000-2001, Clinical Psychology, St. Luke’s/Roosevelt Hospital Center, New York, NY Post-Doctoral Fellow, 2001-2003, University of Pennsylvania APA-Accredited Pre-Doctoral Internship, 1999 -2000, Clinical Psychology, St. Luke’s/Roosevelt Hospital Center, New York, NY ACADEMIC APPOINTMENTS Assistant Professor, David Geffen School of Medicine, Harbor-UCLA Medical Center Director, Adolescent Dialectical Behavior Therapy (DBT) and Adolescent Cognitive-Behavioral Therapy (CBT) Programs, Harbor-UCLA Medical Center, LA BioMed AWARDS & RECOGNITIONS LA BioMed Young Investigator Award, 2012 Best Paper of the Year Award (2008), International Society for Self and Identity, Self and Identity NIMH Travel Award to attend the Child Depression Research Consortium (2005), University of Pittsburgh Invited Partipant: Summer Research Institute in Suicide Prevention Meeting, sponsored by NIMH, University of Rochester, Center for the Study and Prevention of Suicide PUBLICATIONS Recent and/or Significant Studies: An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatment. Asarnow JR, Baraff LJ, Berk M, Grob CS, Devich-Navarro M, Suddath R, Piacentini JC, Rotheram-Borus MJ, Cohen D, Tang L. Psychiatr Serv. 2011 Nov;62(11):1303-9. Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study. Asarnow JR, Porta G, Spirito A, Emslie G, Clarke G, Wagner KD, Vitiello B, Keller M, Birmaher B, McCracken J, Mayes T, Berk M, Brent DA. J Am Acad Child Adolesc Psychiatry. 2011 Aug;50(8):772-81. Epub 2011 Jun 11. Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings. Kennard BD, Clarke GN, Weersing VR, Asarnow JR, Shamseddeen W, Porta G, Berk M, Hughes JL, Spirito A, Emslie GJ, Keller MB, Wagner KD, Brent DA. J Consult Clin Psychol. 2009 Dec;77(6):1033-41.

No Logo Available	Carol D. Berkowitz, M.D. Principal Investigator Executive Vice Chair, Department of Pediatrics, Professor of Pediatrics Work LA BioMed 1124 W. Carson Street, Box 437 Department of Pediatrics/General and Emergency Torrance CA 90502 work Work Phone: 310.222.3091work Work Email: carolb@pol.netINTERNET
Show Bio	Show Map \|
Biography OVERVIEW We are sorry for the inconvenience. This page is currently being updated. Please try again later. Thank you.

No Logo Available	László Boros, M.D. Principal Investigator Department of Pediatrics Work LA BioMed 1124 W. Carson Street Torrance CA 90502 work Work Phone: 310.478.1424 Ext: 304work Work Email: Boros@LABiomed.orgINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Dr. Boros holds a Doctor of Medicine (M.D.) degree from the Albert Szent-Györgyi School of Medicine from Szeged, Hungary. Dr. Boros currently is an Associate Professor of Pediatrics, Endocrinology and Metabolism at the UCLA School of Medicine and Chief Scientific Advisor of SiDMAP, LLC. Dr. Boros is the co-inventor of the stable isotope-based dynamic metabolic profiling (SIDMAP) technology and its applications for drug positioning that involves library screening, lead optimization and in vitro and in vivo phenotype profiling of living cell and host systems via flux measurements using heavy isotope labeled substrates with ¹³C or ²H (deuterium). EDUCATION Doctor of Medicine (M.D.) 1981 – 1987 Szeged School of Medicine. Szeged, Hungary ACADEMIC APPOINTMENTS Investigator, UCLA Clinical and Translational Science Institute (CTSI), Harbor-UCLA, Research Center, Torrance, CA, USA. Jul 2011 – present Chief Scientist, SIDMAP, LLC., Los Angeles, CA, USA. Aug 2004 – present Associate Professor, Departments of Endocrinology & Pediatrics, UCLA School of Medicine, Los Angeles, CA, USA. Jul 2004 – present Co-Director BioMedical Mass Spectroscopy Research Laboratory, Los Angeles Biomedical Research Institute at the Harbor-UCLA, Torrance, CA, USA. Dec 1998 – Apr 2004 Assistant Professor, Departments of Endocrinology & Pediatrics, UCLA School of Medicine, Los Angeles, CA, USA Sep 1998 – Jun 2004 Research Scientist Division of General Surgery, The OhioStateUniversityCollege of Medicine, Columbus, OH, USA. May 1996 – Aug 1998 Medical Student Research Advisor The OhioStateUniversityCollege of Medicine, Columbus, OH, USA Jan 1995 – Aug 1998 Research Associate 2-B/H, Postdoctoral Researcher Division of General Surgery, The Ohio State University College of Medicine, Columbus, OH, USA Jun 1990 – May 1996 Visiting Scholar Essen University Medical School Department of Internal Medicine, Essen, Germany Jan 1989 – May 1990 Postgraduate Research Fellow Hungarian Academy of Sciences, Budapest, Hungary Sept 1987 – Dec 1989 AWARDS & RECOGNITIONS Three-year domestic research fellowship award of the HungarianAcademy of Sciences (1987) C. Williams Hall Outstanding Publication Award – Academy of Surgical Research of the USA (1997) American Society for Leukocyte Biology(ASLA; 1992-1995) American Association for Cancer Research (AACR; 1998-2012; Membership No: 70054) American Pancreatic Association (APA; 1998-present) The American Physiological Society (APS; 1998-2010; Membership No: 31927) Richard E. Weitzman Memorial Research Award – University of California, Los Angeles, CA, USA, June 2001 American Gastroenterological Association (AGA; 2002-2007; Membership No: 902797) Excellence in Clinical Research Award – GCRC at Harbor-UCLAMedicalCenter, September 2004 Metabolomics Society (2004-present; Membership No: 04942012) Géza Hetényi Memorial Membership Award of the Hungarian Gastroenterological Society (2007) Public Health Impact Investigator Award of the United States Food and Drug Administration (2011) PUBLICATIONS Recent and/or Significant Studies: Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Boros LG, Cascante M, Lee WN. Drug Discov Today. 2002 Mar 15;7(6):364-72. Review. Defective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA). Boros LG, Steinkamp MP, Fleming JC, Lee WN, Cascante M, Neufeld EJ. Blood. 2003 Nov 15;102(10):3556-61. Epub 2003 Jul 31. A metabolic hypothesis of cell growth and death in pancreatic cancer. Boros LG, Lee WN, Go VL. Pancreas. 2002 Jan;24(1):26-33. Review.

	Kevin W. Bruhn, Ph.D. Principal Investigator Molecular Medicine Work Hanley-Hardison Research Building Room 207 1124 W. Carson Street Torrance CA 90502 work Work Phone: 310.781.1475work Work Email: kbruhn@labiomed.orgINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Dr. Bruhn’s laboratory is interested in fundamental questions related to host defense and cell-mediated immunity. His focus is on immunotherapeutic approaches that harness the immune system’s ability to recognize and respond to microbial pathogens, as well as tumors. A main area of research is mechanisms of host resistance against the protozoan parasite Leishmania, an immunosuppressive intracellular pathogen that affects millions worldwide, and for which there exists no reliable vaccine. EDUCATION B.A., University of Pennsylvania, 1991 Ph.D., UCLA, 2004 ACADEMIC APPOINTMENTS Assistant Researcher, Division of Molecular Medicine, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA Co-director, Center for Immunotherapeutics Research, LA BioMedical Research Institute AWARDS & RECOGNITIONS Liu Young Investigator Award, LA BioMed, 2009 PUBLICATIONS Recent and/or Significant Studies: Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis. Bruhn, K.W., Birnbaum, R., Haskell, J., Vanchinathan, V., Greger, S., Narayan, R., Chang, P.-L., Tran, T.A., Hickerson, S.M., Beverley, S.M., Wilson, M.E., and Craft, N. (2012) Clin. Vaccine Immunol., 19(4):490-8. Immunomodulation by imiquimod in patients with high-risk melanoma. Narayan, R., Nguyen, H., Bentow, J.J., Moy, L., Lee, D.K., Greger, S., Haskell, J., Vanchinathan, V., Chang, P.L., Tsui, S,, Konishi, T., Comin-Anduix, B., Dauphine, C., Vargas, H., Economou, J.S., Ribas, A., Bruhn, K.W., and Craft, N. (2012) Journal Invest. Dermatol., 132(1):163-9. LXR Deficiency Confers Increased Protection Against Visceral Leishmania Infection in Mice. Bruhn, K.W., Marathe, C., Maretti-Mira, A.C., Nguyen, H., Haskell, J., Tran, T.A., Vanchinathan, V., Gaur, U., Wilson, M.E., Tontonoz, P., and Craft, N. (2010) PLoS Negl. Trop. Dis. 4(11):e886.

	Matthew J. Budoff, M.D. Principal Investigator Cardiology, Director of Cardiac CT Work LA BioMed Research Institute 1124 West Carson Street RB-2 Torrance CA 90502 work Home Fax: 310.222.4107homefax Work Email: mbudoff@labiomed.orgINTERNET
Show Bio	Show Map \|
Biography OVERVIEW CTRC – Core Lab Services Cardiac CTA Training (Level II and III) Professor of Medicine, David Geffen School of Medicine, Harbor-UCLA Medical Center Program Director and Director of Cardiac CT, Division of Cardiology, Harbor-UCLA Medical Center Attending Physician, Department of Medicine, Harbor-UCLA Medical Center Investigator, LA BioMed Dr. Matthew Budoff is at the forefront of the medical community’s efforts to develop early detection methods for cardiac disease, the number one cause of death in the U.S. Given that approximately 50 percent of U.S. heart disease victims learn of their illness by experiencing a sometimes fatal heart attack, Dr. Budoff has devoted much of his time over the past 20 years to advancing procedures that can help doctors identify cardiac patients early, and place them on a therapeutic path to prevent a heart attack. Besides his work on early detection of heart disease, Dr. Budoff is pursuing funded research to better understand the second highest cause of death in the U.S., lung disease, and its potential cardiologic correlations. He also participates in research examining the link between diabetes in young adults and heart disease. Finally, he recently completed a study looking at the incidence of heart disease among firefighters. Dr. Budoff works on at least 50 active medical research trials at any given time, and is a frequent lecturer on topics of cardiology at symposia, congresses and annual conferences on every continent. He has authored or co-authored over 400 research papers, six books, and 36 book chapters. In the past two years alone, Dr. Budoff has been honored with a dozen awards recognizing his professional skills and accomplishments. Of note is his receipt of the Einstein Award for Scientific Achievement from the International Biographical Centre, Cambridge, U.K.; the Top Oral Abstract at the American Heart Association’s 2009 meeting; his inclusion in five respected lists of top doctors in America; and, most recently, being named to the US News list of Top Doctors for 2011. Dr. Budoff graduated cum laude from the University of California, Riverside, with a major in biochemistry. He went on to graduate with distinction from the George Washington University School of Medicine in Washington, DC, receiving the school’s highest honor: Alpha Omega Alpha (Medical Honor Society). Dr. Budoff returned to his native California to complete an internship and residency in internal medicine, and a fellowship in cardiology, at Harbor-UCLA Medical Center in Torrance. EDUCATION M.D., 1990, George Washington University School of Medicine Fellowship, 1994-1997, Cardiology, Harbor-UCLA Medical Center Internship and Residency, 1990-1993, Internal Medicine, Harbor – UCLA ACADEMIC APPOINTMENTS Professor of Medicine, David Geffen School of Medicine, Harbor-UCLA Medical Center Program Director and Director of Cardiac CT, Division of Cardiology, Harbor-UCLA Medical Center Attending Physician, Department of Medicine, Harbor-UCLA Medical Center Investigator, LA BioMed AWARDS & RECOGNITIONS US News Top Doctors – Cardiology, 2011 Simon Dack Award for Outstanding Scholarship, 2011 Who’s Who in America, 2011 America’s Top Doctors, 2009, 2011 Southern California Superdoctors 2011 America’s Top Cardiologists, 2010 2000 Outstanding Scientists, 2010 Top Oral Abstract at American Heart Association, 2009 PUBLICATIONS Recent and/or Significant Studies: Beneficial effects of aged garlic extract and coenzyme Q10 on vascular elasticity and endothelial function: The FAITH randomized clinical trial. Larijani VN, Ahmadi N, Zeb I, Khan F, Flores F, Budoff M. Nutrition. 2012 Aug 1. Interpreting the coronary-artery calcium score. Budoff MJ. N Engl J Med. 2012 Apr 19;366(16):1550-1 Coronary calcium and events in four ethnic groups. Nasir K, Budoff MJ, Blumenthal R. N Engl J Med. 2008 Jul 10;359(2):203; author reply 204.

	Karl S. Burgoyne, M.D. Principal Investigator Associate Professor of Psychiatry Work LA BioMed 1124 W. Carson Street, Bldg. D-5 Torrance CA 90502 work Work Phone: 310.222.3135work Work Email: kburgoyne@dhs.lacounty.govINTERNET
Show Bio	Show Map \|
Biography OVERVIEW We are sorry for the inconvenience. This page is currently being updated. Please try again later. Thank you.

A B C D

	Richard Casaburi, Ph.D., M.D Principal Investigator Division of Respiratory Medicine Work Division of Respiratory and Critical Care Physiology and Medicine Harbor-UCLA Medical Center 1124 West Carson St., Building J4 Torrance CA 90502 work Home Fax: 310.222.8200homefax Work Email: casaburi@ucla.eduINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Associate Chief for Research, Division of Respiratory and Critical Care Physiology and Medicine, Harbor-UCLA Medical Center Professor of Medicine, David Geffen Medical School, Harbor-UCLA Medical Center Director, Clinical Respiratory Physiology Laboratories Medical Director, Rehabilitation Clinical Trials Center, LA BioMed Dr. Richard Casaburi began his research career by studying mechanisms of exercise intolerance. Over the past 25 years, he has focused on Chronic Obstructive Pulmonary Disease (COPD), now the third leading cause of death in the United States. In 1999, Dr. Casaburi established the Rehabilitation Clinical Trials Center, a clinical research facility dedicated to improving the lives of COPD patients. In collaboration with Dr. Janos Porszasz, the laboratory’s technical director, Dr. Casaburi has completed more than 50 clinical research studies, including participation in three major NIH multicenter projects. Dr. Casaburi is a Fellow of the American College of Chest Physicians and the American Association of Cardiovascular and Pulmonary Rehabilitation, and a member of the American Physiological Society and American Thoracic Society. An editorial board member of the Journal of Cardiopulmonary Rehabilitation, Proceedings of the American Thoracic Society and COPD, he also has given over 500 invited lectures and authored more than 210 publications and 185 abstracts. In addition to holding the Alvin Grancell/Mary Burns Endowed Chair in the Rehabilitative Sciences at LA BioMed, Dr. Casaburi serves as president of the Pulmonary Education and Research Foundation, a non-profit corporation dedicated to advancing the scientific basis and practice of pulmonary rehabilitation. A native of New York, Dr. Casaburi began his collegiate career by pursuing a degree in electrical engineering from Rennselaer Polytechnic Institute (RPI.) He followed with a master’s degree and doctorate in biomedical engineering, also from RPI, before completing a post-doctoral fellowship in biomedical engineering at USC. Five years after joining the Department of Medicine faculty at Harbor-UCLA, Dr. Casaburi returned to school to pursue his medical degree at the University of Miami, School of Medicine in Florida. He returned to Harbor-UCLA Medical Center in 1980, where he completed an internship, residency and pulmonary fellowship and rejoined the faculty of the Division of Respiratory Medicine. He became chief of the division in 1998 and served in this position for six years. EDUCATION Ph.D., 1971, Biomedical Engineering, Rensselaer Polytechnic Institute Post-Doctoral Fellowship, 1971-1973, Biomedical Engineering, University of Southern California M.D., Ph.D. to M.D. Program, 1980, University of Miami School of Medicine Internship, 1980-1981, Straight Medical Intern, Harbor-UCLA Medical Center Residency, 1981-1983, Internal Medicine, Harbor-UCLA Medical Center Pulmonary Fellowship, 1983-1984, Division of Respiratory and Critical Care Physiology and Medicine, Harbor-UCLA Medical Center ACADEMIC APPOINTMENTS Associate Chief for Research, Division of Respiratory and Critical Care Physiology and Medicine, Harbor-UCLA Medical Center Professor of Medicine, UCLA School of Medicine Director, Blood Gas Laboratory Medical Director, Rehabilitation Clinical Trials Center, LA BioMed AWARDS & RECOGNITIONS Alvin Grancell/Mary Burns Endowed Chair in the Rehabilitative Sciences at LA BioMed President, Pulmonary Education and Research Foundation California Medal of the American Lung Association of California Mary Burns Award of the California Society for Pulmonary Rehabilitation Michael L. Pollock Established Investigator Award, American Association for Cardiovascular and Pulmonary Rehabilitation Moran Campbell Memorial Lectureship of the British Thoracic Society PUBLICATIONS Recent and/or Significant Studies: Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. Casaburi R, ZuWallack R. N Engl J Med. 2009 Mar 26;360(13):1329-35 A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. Casaburi R, Porszasz J, Hecht A, Tiep B, Albert RK, Anthonisen NR, Bailey WC, Connett JE, Cooper JA Jr, Criner GJ, Curtis J, Dransfield M, Lazarus SC, Make B, Martinez FJ, McEvoy C, Niewoehner DE, Reilly JJ, Scanlon P, Scharf SM, Sciurba FC, Woodruff P; COPD Clinical Research Network.

	Daniel Castro, M.D. Principal Investigator Chair, Department of Family Medicine Work Harbor-UCLA Medical Center 1403 W. Lomita Boulevard, Suite 102 Harbor City CA 90710 work Work Phone: 310.534.6221work Work Email: harborfp@aol.comINTERNET
Show Bio	Show Map \|
Biography OVERVIEW We are sorry for the inconvenience. This page is currently being updated. Please try again later. Thank you.

	Rowan T. Chlebowski, M.D., Ph.D. Principal Investigator Medical Oncology / Hematology Work Division of Medical Oncology and Hematology Harbor-UCLA Medical Center 1124 West Carson St. Torrance CA 90502 work Work Phone: 310.222.2217work Work Email: rowanchlebowski@gmail.comINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Dr. Rowan Chlebowski’s work within UCLA’s medical community focuses on his major research interests: breast cancer therapy and prevention, and chronic diseases impacting women’s health. EDUCATION M.D., 1974, Case Western Reserve University School Of Medicine, Cleveland, OH Clinical Instructor Medical Oncology, University of Southern California, Los Angeles County USC Medical Center Residency, 1974-1976, Internal Medicine, Cleveland Metropolitan General Hospital Internship, 1974-1976, Internal Medicine, Cleveland Metropolitan General Hospital ACADEMIC APPOINTMENTS Chief, Division of Medical Oncology and Hematology, Harbor-UCLA Medical Center Professor of Medicine, David Geffen School of Medicine, Harbor-UCLA Medical Center Investigator, LA BioMed AWARDS & RECOGNITIONS America’s Top Doctors (Castle Connolly Guide) – Selection based on nomination and nationwide vote by physician peers – ”Top Doctor Medical Oncology,” 2001-2010 PUBLICATIONS Recent and/or Significant Studies: The Aromatase Gene (CYP19A1) Variants and Circulating Hepatocyte Growth Factor in Postmenopausal Women. Lin JH, Gunter MJ, Manson JE, Rexrode KM, Cook NR, Kraft P, Cochrane BB, Chlebowski RT, Ho GY, Zhang SM. PLoS One. 2012;7(7):e42079. Epub 2012 Jul 25. Metformin and breast cancer risk: a meta-analysis and critical literature review. Col NF, Ochs L, Springmann V, Aragaki AK, Chlebowski RT. Breast Cancer Res Treat. 2012 Jul 31. Birth weight, breast cancer and the potential mediating hormonal environment. Bukowski R, Chlebowski RT, Thune I, Furberg AS, Hankins GD, Malone FD, D’Alton ME. PLoS One. 2012;7(7):e40199. Epub 2012 Jul 17.

	Tsui-Fen Chou, Ph.D. Principal Investigator Department of Pediatrics Work Harbor-UCLA Medical Center 1124 W. Carson Street CHRC Room 120 Torrance CA 90502 work Work Phone: 424.201.3006work Work Phone: 424.201.3009work Work Email: tchou@labiomed.orgINTERNET Work Email: tsuifenchou@ucla.eduINTERNET
Show Bio	Show Map \|
Biography OVERVIEW We are employing a combination of chemical biology, quantitative proteomics, high throughput, high-content screenings, and biochemical reconstitution to study the mechanism by which p97 orchestrates two major protein clearance pathways, proteasome and autophagy, and regulates the activity of proteins involved in apoptosis. In particular, we are using our novel p97 inhibitors in combination with genetic inhibition by RNAi or a dominant negative p97 mutant in proteomic experiments to identify substrates and investigate cell biological functions of p97. Our work will generate important biomarkers for evaluating the harmacodynamics of the anti-cancer effects of p97 inhibitors in future animal studies and will facilitate the development of novel therapeutic agents. EDUCATION Postdoctoral Fellow, Biology, Feb. 2007 – June 2012 Howard Hughes Medical Institute, California Institute of Technology, Pasadena Ph.D. in Medicinal Chemistry, July 2006 University of Minnesota, Twin Cities, USA B.S. in Pharmacy, June 1999 School of Pharmacy, National Taiwan University, Taipei, Taiwan ACADEMIC APPOINTMENTS Assistant Professor, Department of Pediatrics, July 2012 – Current Division of Medical Genetics David Geffen School of Medicine, UCLA Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute AWARDS & RECOGNITIONS 1996,1997 Presidential Award (Dean’s List), National Taiwan Unviersity 1997 Student Research Fellowship, National Science Council, Taiwan, 1996-1999 Study Fellowship, Standard Chemical & Pharmaceutical Company, Taiwan 1999 Outstanding College Youth, National Taiwan Unviersity 2004 Poster Award: The XVI International Roundtable (IRT) on Nucleosides, Nucleotides and NucleicAcids. Minneapolis, MN. 2004 Poster Award: International Symposium for Chinese Medicinal Chemists, Taipei, Taiwan. 2006 ASBMB Travel Award, the Experimental Biology 2006 Meeting, San Francisco. 2006 ACS Travel Award, Division of Biological Chemistry, 232th National Meeting of the American Chemical Society, San Francisco. 2008 ASBMB Travel Award, the Experimental Biology 2008 Meeting, San Diego 2010 Ubiquitin Drug Discovery and Diagnostic Conference Travel Award, Philadelphia. 2011 Aspen Cancer Conference Fellowship Award, Aspen, July 10 – 12, 2011. PUBLICATIONS Recent and/or Significant Studies: Quantitative cell-based protein degradation assays to identify and classify drugs that target the ubiquitin-proteasome system. Chou TF, Deshaies RJ. J Biol Chem. 2011 May 13;286(19):16546-54. Epub 2011 Feb 22. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Chou TF, Brown SJ, Minond D, Nordin BE, Li K, Jones AC, Chase P, Porubsky PR, Stoltz BM, Schoenen FJ, Patricelli MP, Hodder P, Rosen H, Deshaies RJ. Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4834-9. Epub 2011 Mar 7. Development of p97 AAA ATPase inhibitors. Chou TF, Deshaies RJ. Autophagy. 2011 Sep;7(9):1091-2. Epub 2011 Sep 1.

	Bowen Chung, M.D. Principal Investigator Department of Psychiatry Home Harbor-UCLA Medical Center 1000 West Carson Street Box 498 Torrance CA 90509 home Work Phone: 310.222.1801work Work Email: bchung@mednet.ucla.eduINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Dr. Chung’s career interests are in community based participatory research, the dissemination and implementation of quality improvement approaches for depression care, health disparities, and quality of care in low income urban communities. Dr. Chung has received research funding from the National Institute of Mental Health, the National Institute of Child and Human Development, the National Library of Medicine; as well as several local foundations such as the California Community Foundation and the California Endowment. He is currently co-leading a 2 year grant, Building Resiliency and Increasing Community Hope (B-RICH), funded by the California Community Foundation with his community partners, 1st African Presbyterian Church and Healthy African American Families II. The goal of B-RICH is to evaluate an adapted Cognitive Behavioral Psycho-Educational Intervention (a Resiliency Class) to be delivered by non-professionals in community agencies and churches in South Los Angeles. In addition, he is leading a pilot funded by the UCLA CTSI to conduct a cost-effectiveness analysis of a quality improvement intervention for depression care, Community Partners in Care (PI Wells). And last, he is a co-PI on a recently funded grant through the NIMH (PI Miklowitz) that seeks to understand how to implement an evidence-based therapy for bipolar and psychotic youth, Family Focused Therapy, in community agencies. Dr. Chung is a co-investigator within the UCLA Clinical and Translational Science Institute’s Community Engagement and Research Program and the UCLA Center for Health Services and Society. EDUCATION 1993 Williams College, B.A. English Literature 1998 Mount Sinai School of Medicine, M.D. 2001 UCLA Neuropsychiatric Hospital, Internship and General Psychiatry Residency 2003 UCLA Neuropsychiatric Hospital, Child and Adolescent Psychiatry Fellowship 2005 Robert Wood Johnson Clinical Scholars Program at UCLA / RAND 2005 UCLA School of Public Health, M.S.H.S. with a focus in Health Services ACADEMIC APPOINTMENTS Post-Doctoral Research Fellow, Center for Health Services and Society, Semel Institue for Neuroscience and Human Behavior, Geffen School of Medicine at UCLA, 2005-2008 Adjunct Scientist, RAND Corporation, 2005-present Assistant Professor, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, 2008-present Investigator, Los Angeles Biomedical Research Institute, 2010-present Research Scientist, Healthy African American Families II, 20010-present PUBLICATIONS Recent and/or Significant Studies: Addressing unmet mental health and substance abuse needs: a partnered planning effort between grassroots community agencies, faith-based organizations, service providers, and academic institutions. Wong Eunice C, Chung Bowen, Stover Gabriel, Stockdale Susan, Jones Felica, Litt Paula, Klap Ruth S, Patel Kavita, Wells Kenneth B Ethnicity & disease, 2011; 21(3 Suppl 1): S1-107-13. Partnered evaluation of a community engagement intervention: use of a kickoff conference in a randomized trial for depression care improvement in underserved communities. Mendel Peter, Ngo Victoria K, Dixon Elizabeth, Stockdale Susan, Jones Felica, Chung Bowen, Jones Andrea, Masongsong Zoe, Khodyakov Dmitry Ethnicity & disease, 2011; 21(3 Suppl 1): S1-78-88. Project overview of the Restoration Center Los Angeles: steps to wholeness–mind, body, and spirit. Chung Bowen, Wong Eunice, Litt Paula, Reverend Ronald Wright Paula, Hill Delores A, Jones Felica, Corbin Dennis, Gray Ruthie, Patel Kavita, Wells Kenneth B Ethnicity & disease, 2011; 21(3 Suppl 1): S1-100-6.

No Logo Available	Julia Chung, M.D. Principal Investigator Assistant Clinical Professor Work LA BioMed Harbor-UCLA Medical Center Department of Psychiatry 1000 W. Carson Street, Bldg. 1-South Torrance CA 90509 work Work Phone: 310.222.8125work Work Email: julchung@dhs.lacounty.govINTERNET
Show Bio	Show Map \|
Biography OVERVIEW We are sorry for the inconvenience. This page is currently being updated. Please try again later. Thank you.

	Noah A. Craft, M.D., Ph.D. Principal Investigator Molecular Medicine Work Hanley-Hardison Research Building Room 207 Harbor-UCLA Medical Center 1124 W. Carson Street Torrance CA 90502 work Work Phone: 310.781.1447work Work Email: ncraft@ucla.eduINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Associate Professor of Medicine, in Residence, Harbor-UCLA Medical Center, Department of Medicine, Divisions of Dermatology and Infectious Diseases Course Director of General Dermatology at Harbor-UCLA Medical Center Dermatology Curriculum Director, UCLA School of Medicine Director of Teledermatology, Harbor-UCLA Medical Center Associate Residency Program Director, Harbor-UCLA Dermatology Director of the Center for Immunotherapeutics Research, LA BioMed Dr. Noah Craft’s current research focuses on developing vaccines and immunotherapy for melanoma and leishmaniasis. He also has been working on studies to understand the human skin microbiome, or the microorganisms that live peacefully on our skin. Dr. Noah Craft, a specialist in dermatology with a focus on infectious diseases, is a lead investigator for LA BioMed who has pioneered diagnostic technologies for dermatological use. He is an advocate for educating the medical community and the public about a wide variety of dermatologic issues. Working within the LA BioMed framework, Dr. Craft helped develop a software product called VisualDx that is expected to significantly reduce misdiagnoses of skin ailments, especially in cases where time is of the essence. Dr. Craft found that VisualDx helped to correctly diagnose 64% of emergency room dermatology cases where there originally had been a misdiagnosis as skin infections. Dr. Craft’s research reflects his diverse training and interests. His current research focuses on developing vaccines and immunotherapy for melanoma and leishmaniasis. He also has been working on studies to understand the human skin microbiome, or the microorganisms that live peacefully on our skin. In addition to his laboratory research, he is working on innovative educational technologies and studies to improve diagnostic accuracy in underserved populations and patients with darker skin types. Through work in the criminal justice system, he has pioneered ways to identify potential criminals from photographs of the skin. He has funding from the NIH and several private foundations to support his work. During the course of his professional career, Dr. Craft has published more than 60 research articles and chapters on subjects including melanoma, vaccines, immunotherapy, parasites, leishmaniasis, diagnostic accuracy, and skin infections. Dr. Craft received his bachelor’s degree in biology from Brown University. Venturing west for medical school, he earned his medical doctorate and Ph.D. (molecular biology) from UCLA. He followed these accomplishments with an internship in internal medicine, a residency in dermatology and a Specialty Training & Advanced Research (STAR) fellowship through UCLA’s Division of Dermatology and Department of Microbiology, Immunology, and Molecular Genetics. He also completed a diploma in Tropical Medicine and Hygiene from the London School of Hygiene and Tropical Medicine. EDUCATION M.D., Ph.D., 2000, Molecular Biology, UCLA School of Medicine Fellowship, 2001-2005, Dermatology/Microbiology UCLA Department of Medicine – Specialty Training & Advanced Research (STAR) Program Microbiology and Immunology, 2002-2005, UCLA Department of Microbiology, Immunonology and Molecular Genetics (Post-Doctorate) Tropical Medicine, 2005, London School of Hygiene and Tropical Medicine (DTMH) Residency, 2001-2005, UCLA Division of Dermatology Internship, 2000-2001, Internal Medicine, Olive View County Hospital, Sylmar, CA (UCLA) ACADEMIC APPOINTMENTS Associate Professor of Medicine, in Residence, Harbor-UCLA Medical Center, Department of Medicine, Divisions of Dermatology and Infectious Diseases Course Director of General Dermatology at Harbor-UCLA Medical Center Dermatology Curriculum Director, UCLA School of Medicine Director of Teledermatology, Harbor-UCLA Medical Center Associate Residency Program Director, Harbor-UCLA Dermatology Director of the Center for Immunotherapeutics Research, LA BioMed AWARDS & RECOGNITIONS World Congress of Dermatology Scholarship Travel Award for Presentation of Research, 2002 Dermatology Foundation Research Investigator Award — Postdoctoral Funding, 2003 Editorial Board, Logical Images, Inc.; Section Editor, Tropical Dermatology, 2003 NIH Clinical and Fundamental Immunology Training Award, 2004 Victor D. Newcomber Award for Excellence in Dermatology Research, 2004 PUBLICATIONS Recent and/or Significant Studies: Possible links between sickle cell crisis and pentavalent antimony. Garcerant D, Rubiano L, Blanco V, Martinez J, Baker NC, Craft N. Am J Trop Med Hyg. 2012 Jun;86(6):1057-61. Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species. Rodriguez-Pinto D, Navas A, Blanco VM, Ramírez L, Garcerant D, Cruz A, Craft N, Saravia NG. PLoS Negl Trop Dis. 2012 Apr;6(4):e1627. Epub 2012 Apr 24. Dermatologic care in the homeless and underserved populations: observations from the Venice Family Clinic. Grossberg AL, Carranza D, Lamp K, Chiu MW, Lee C, Craft N. Cutis. 2012 Jan;89(1):25-32.

	John Michael Criley, M.D. Principal Investigator Professor of Medicine and Radiological Sciences Work LA BioMed 1124 W. Carson Street, Bldg. RB-2 Department of Medicine/Cardiology Torrance CA 90502 work Work Phone: 310.222.2532work Work Email: jmcriley@ucla.eduINTERNET
Show Bio	Show Map \|
Biography EDUCATION John Marshall High School W 1949 Stanford University Basic Medical Sciences 1953 Stanford University School of Medicine 1956 Residency & Fellowshio: Johns Hopkins Hospital 1956-1962 ACADEMIC APPOINTMENTS Assistant Professor of Medicine and Radiology, Johns Hopkins School of Medicine 1962-67 Associate Professor of Medicine and Radiological Sciences, UCLA School of Medicine 1967-73 Professor of Medicine and Radiological Sciences, UCLA School of Medicine 1973-1999 Emeritus Professor of Medicine and Radiological Sciences, UCLA School of Medicine 1999- AWARDS & RECOGNITIONS American Heart Association Great Teachers Program 1969 Special Recognition Award Laennec Society 1997 Johns Hopkins University Society of Scholars 1972 Harbor-UCLA Medical Center Kouichi Tanaka Distinguished Teacher Award 2006 American College of Physicians Distinguished Teacher Award 2009

A B C D

	Eric S. Daar, M.D. Principal Investigator HIV Medicine Research Work Division of HIV Medicine Harbor-UCLA Medical Center 1124 W. Carson Street Torrance CA 90502 work Work Phone: 310.222.2467work Work Email: edaar@labiomed.orgINTERNET Work Email: edarr@rei.eduINTERNET
Show Bio	Show Map \|
Biography OVERVIEW Chief, Division of HIV Medicine, Harbor-UCLA Medical Center Professor of Medicine, David Geffen School of Medicine, Harbor-UCLA Medical Center Investigator, LA BioMed Dr. Eric Daar is an infectious diseases-trained clinician-investigator with nearly 20 years of experience conducting clinical and translational research related to HIV/AIDS. He has authored more than 300 peer-reviewed articles and abstracts on the topic, and is involved in the care of approximately 1,200 HIV-infected patients. Dr. Daar’s research focuses on management of HIV-1 infection and its complications, as well as on the immunopathogenesis of primary and chronic HIV-1 infection. He is a member of the editorial board for Current HIV/AIDS Reports, AIDS, the Open Infectious Diseases Journal, and AIDS Research and Treatment. He serves on the editorial advisory board of the Journal of Infectious Diseases, and is a reviewer for numerous other scientific journals. Dr. Daar serves as chair of the Antiretroviral Strategies Scientific Subcommittee of the AIDS Clinical Trials Group and the NIH Prevention Trials Data Safety Monitoring Board. He also is a member of the United States Health and Human Services (HHS) Guidelines Panel for Antiretroviral Therapy for Adults and Adolescents. Dr. Daar earned his bachelor’s degree from UCLA before going on to receive his medical degree from Georgetown University. A residency in internal medicine and a fellowship in infectious diseases followed at Cedars-Sinai Medical Center and UCLA. He has earned several prestigious awards throughout his career, including the Golden Apple Award for Medical Education from Cedars-Sinai Medical Center, and UCLA’s Award for Excellence in Education. EDUCATION M.D., 1985, Georgetown University School of Medicine Fellowship, 1987-1991, Infectious Diseases, Cedars-Sinai Medical Center Residency, 1985-1987, Internal Medicine, Cedars-Sinai Medical Center Internship, 1985-1987, Internal Medicine, Cedars-Sinai Medical Center ACADEMIC APPOINTMENTS Chief, Division of HIV Medicine, Harbor-UCLA Medical Center Professor of Medicine, David Geffen School of Medicine, Harbor-UCLA Medical Center Investigator, LA BioMed AWARDS & RECOGNITIONS UCLA Award for Excellence in Education, 2000 Golden Apple Award for Medical Education, Cedars-Sinai Medical Center, 1995, 1998 Morris Press Humanism Award for Attending Staff, Cedars-Sinai Medical Center, 1994 Ben Newman Award for Resident Achievement, Cedars-Sinai Medical Center,1988 Alpha Omega Alpha Honor Society, Georgetown University, 1984 PUBLICATIONS Recent and/or Significant Studies: Role of GB Virus C in Human Immunodeficiency Virus Type-1- and Hepatitis C Virus-infected Hemophiliac Children and Adolescents. Tenckhoff S, Kaiser T, Bredeek F, Donfield S, Menius E, Lail A, Mössner J, Daar ES, Tillmann HL. J Acquir Immune Defic Syndr. 2012 Jun 13. Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Sax PE. AIDS. 2012 Jul 17;26(11):1371-1385. The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. Hogan CM, Degruttola V, Sun X, Fiscus SA, Del Rio C, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima KT, Kallungal B, Camp R, Morton T, Daar ES, Little S; A5217 Study Team. J Infect Dis. 2012 Jan 1;205(1):87-96. Epub 2011 Dec 15.